Microbiome-derived carnitine mimics as previously unknown mediators of gut-brain axis communication

Hulme, Heather and Meikle, Lynsey M. and Strittmatter, Nicole and van der Hooft, Justin J. J. and Swales, John and Bragg, Ryan A. and Villar, Victor H. and Ormsby, Michael J. and Barnes, Stephanie and Brown, Sheila L. and Dexter, Alex and Kamat, Maya T. and Komen, Jasper C. and Walker, Daniel and Milling, Simon and Osterweil, Emily K. and MacDonald, Andrew S. and Schofield, Chris J. and Tardito, Saverio and Bunch, Josephine and Douce, Gillian and Edgar, Julia M. and Edrada-Ebel, RuAngelie and Goodwin, Richard J.A. and Burchmore, Richard and Wall, Daniel M. (2020) Microbiome-derived carnitine mimics as previously unknown mediators of gut-brain axis communication. Science Advances, 6 (11). eaax6328. ISSN 2375-2548 (https://doi.org/10.1126/sciadv.aax6328)

[thumbnail of Hulme-etal-SA-2020-Microbiome-derived-carnitine-mimics-as-previously-unknown-mediators]
Preview
Text. Filename: Hulme_etal_SA_2020_Microbiome_derived_carnitine_mimics_as_previously_unknown_mediators.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (778kB)| Preview

Abstract

Alterations to the gut microbiome are associated with various neurological diseases, yet evidence of causality and identity of microbiome-derived compounds that mediate gut-brain axis interaction remain elusive. Here, we identify two previously unknown bacterial metabolites 3-methyl-4-(trimethylammonio)butanoate and 4-(trimethylammonio)pentanoate, structural analogs of carnitine that are present in both gut and brain of specific pathogen-free mice but absent in germ-free mice. We demonstrate that these compounds are produced by anaerobic commensal bacteria from the family Lachnospiraceae (Clostridiales) family, colocalize with carnitine in brain white matter, and inhibit carnitine-mediated fatty acid oxidation in a murine cell culture model of central nervous system white matter. This is the first description of direct molecular inter-kingdom exchange between gut prokaryotes and mammalian brain cells, leading to inhibition of brain cell function.